1. Academic Validation
  2. Loss of the protein-tyrosine phosphatase DEP-1/PTPRJ drives meningioma cell motility

Loss of the protein-tyrosine phosphatase DEP-1/PTPRJ drives meningioma cell motility

  • Brain Pathol. 2011 Jul;21(4):405-18. doi: 10.1111/j.1750-3639.2010.00464.x.
Astrid Petermann 1 Daniela Haase Andrea Wetzel Kamal K Balavenkatraman Tencho Tenev Karl-Heinz Gührs Sabrina Friedrich Makoto Nakamura Christian Mawrin Frank-D Böhmer
Affiliations

Affiliation

  • 1 Institute of Molecular Cell Biology, Center for Molecular Biomedicine, Jena, Germany.
Abstract

DEP-1/PTPRJ is a transmembrane protein-tyrosine Phosphatase which has been proposed as a suppressor of epithelial tumors. We have found loss of heterozygosity (LOH) of the PTPRJ gene and loss of DEP-1 protein expression in a subset of human meningiomas. RNAi-mediated suppression of DEP-1 in DEP-1 positive meningioma cell lines caused enhanced motility and colony formation in semi-solid media. Cells devoid of DEP-1 exhibited enhanced signaling of endogenous platelet-derived growth factor (PDGF) receptors, and reduced paxillin phosphorylation upon seeding. Moreover, DEP-1 loss caused diminished adhesion to different matrices, and impaired cell spreading. DEP-1-deficient meningioma cells exhibited invasive growth in an orthotopic xenotransplantation model in nude mice, indicating that elevated motility translates into a biological phenotype in vivo. We propose that negative regulation of PDGF receptor signaling and positive regulation of adhesion signaling by DEP-1 cooperate in inhibition of meningioma cell motility, and possibly tumor invasiveness. These phenotypes of DEP-1 loss reveal functions of DEP-1 in adherent cells, and may be more generally relevant for tumorigenesis.

Figures